Abstract
Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel "iPDM Goes Europe" consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.
| Originalsprog | Engelsk |
|---|---|
| Sider (fra-til) | 360-364 |
| Antal sider | 5 |
| Tidsskrift | Primary care diabetes |
| Vol/bind | 15 |
| Udgave nummer | 2 |
| Tidlig onlinedato | 9 nov. 2020 |
| DOI | |
| Status | Udgivet - apr. 2021 |
Fingeraftryk
Udforsk hvilke forskningsemner 'Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe' indeholder.Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver